Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-27

Clinical Trial Update: Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial reports that Fu-zheng-qu-zhuo Oral Liquid improves renal function in patients with chronic kidney disease stages 3 and 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fu-zheng-qu-zhuo Oral Liquid

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Stage 3 Chronic Kidney Disease, Stage 4 Chronic Kidney Disease | Phase 2 | Status: COMPLETED